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Abstract 
Background: The genome is under constant assault from a multitude of sources that can lead to the formation of 
DNA double-stand breaks (DSBs). DSBs are cytotoxic lesions, which if left unrepaired could lead to genomic instability, 
cancer and even cell death. However, erroneous repair of DSBs can lead to chromosomal rearrangements and loss of 
heterozygosity, which in turn can also cause cancer and cell death. Hence, although the repair of DSBs is crucial for 
the maintenance of genome integrity the process of repair need to be well regulated and closely monitored.
Main body: The two most commonly used pathways to repair DSBs in higher eukaryotes include non-homologous 
end joining (NHEJ) and homologous recombination (HR). NHEJ is considered to be error-prone, intrinsically muta-
genic quick fix remedy to seal together the broken DNA ends and restart replication. In contrast, HR is a high-fidelity 
process that has been very well conserved from phage to humans. Here we review HR and its sub-pathways. We 
discuss what factors determine the sub pathway choice including etiology of the DSB, chromatin structure at the 
break site, processing of the DSBs and the mechanisms regulating the sub-pathway choice. We also elaborate on the 
potential of targeting HR genes for cancer therapy and anticancer strategies.
Conclusion: The DNA repair field is a vibrant one, and the stage is ripe for scrutinizing the potential treatment 
efficacy and future clinical applications of the pharmacological inhibitors of HR enzymes as mono- or combinatorial 
therapy regimes.
Keywords: DNA damage, DNA repair, Genome editing, Genomic instability, Cancer, Chemotherapy, Double-strand 
break repair, Homologous recombination, Targeted therapy
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Background
DNA double strand breaks (DSBs) result as a conse-
quence of the disassembly of the DNA double helix 
leading to the disruption of the stability of the genome. 
DSBs not only ensue from normal cellular metabolism, 
in the form of reactive oxygen species that can oxi-
dize DNA bases [1, 2], but can also be generated during 
physiological processes like chromosome replication, 
meiotic recombination and DNA replication transcrip-
tion collision [3–7]. Regardless of how DSBs are formed, 
faithful repair of these breaks are absolutely essential 
for maintenance of genome integrity. Failure to repair 
DSBs can lead to unwanted consequences, such as loss 
of genetic information, chromosomal rearrangements 
and even cell death. Cells have evolved with conserved 
recombination mediated genome editing pathways as 
a mean for repairing DSBs and restarting replication 
forks, thus allowing genome duplication to continue [8]. 
Recombination based mechanisms are crucial for both 
the repair and tolerance of DNA damage that vexes both 
strands of the double helix [9].
DNA double strand break repair (DSBR) pathways are 
generally classified based on whether sequence homol-
ogy is used to join the broken DNA ends. Non-homolo-
gous end joining (NHEJ), which does not depend upon 
sequence homology, is the key repair pathway during 
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the G0/G1 stages of the cell cycle [10]. During NHEJ, 
once a DSB is formed the broken ends are bound by 
Ku proteins (ku70 and ku80), which form a heterodi-
mer and insulate the DNA ends from nucleolytic ero-
sion [11, 12]. The Ku proteins foster direct ligation of 
the broken DNA ends by the specialized ligase com-
plex Dnl4–Lif1 [12]. This complex can execute a blunt 
end ligation reaction on clean DNA ends, i.e. 3′-OH 
and 5′-phosphate groups. If the broken DNA ends are 
not clean, then further processing by nucleases and 
polymerases are necessary to ligate the loose ends [12]. 
However, in the midst of this process of genome edit-
ing, small deletions and insertions might be introduced 
at the junction site. This is why this pathway if often 
regarded to be an error-prone recovery mechanism [2, 
13, 14].
In spite of the mutagenicity associated with NHEJ, its 
fast kinetics has a unique role in safeguarding genome 
integrity, particularly by suppressing chromosomal 
translocations [15]. A second NHEJ concomitant path-
way often referred to as alternative-NHEJ (Alt-NHEJ), 
also known as Microhomology-mediated end joining 
(MMEJ), is another well-studied pathway for repairing 
DSBs in DNA [16]. The MMEJ repair pathway displays 
two diverging features from NHEJ; first is the use of 5–25 
base pair (bp) microhomologous sequences during the 
alignment of the broken ends before religating them, and 
second is the slower kinetics of repair [15]. Much like 
NHEJ, MMEJ is frequently associated with chromosome 
anomalies such as deletions, translocations, inversions 
and other complex rearrangements. In contrast to NHEJ, 
there is an error-free DSBR pathway known as Homol-
ogous Recombination (HR) pathway where the cell 
employs a homologous DNA as template for the repair 
of the broken ends [17]. The homologous DNA may be 
a sister chromatid, a homologous chromosome or an 
ectopically located sequence. Further discussion on the 
detailed mechanisms of the repair systems mediated by 
NHEJ is beyond the scope of this review; instead we will 
focus on how DSBs are repaired error-free by HR, the 
various sub-types of HR and the molecular mechanisms 
regulating HR.
Overview of homologous recombination
HR is the process by which DNA molecules of iden-
tical or nearly identical nucleotide sequences interact 
and exchange information that may or may not result 
in rearrangement of genetic information [18]. HR is 
widely considered as the major repair pathway in the 
mid-S and mid-G2 cell cycle phases, where DNA rep-
lication is maximum and therefore the sister template 
is accessible [18]. HR has three major steps: presyn-
apsis, synapsis, and postsynapsis (Fig.  1). Mechanis-
tically, in the presynaptic step, the DSB is resected 
enzymatically to generate ssDNA tails with 3′ ends [19, 
20]. The ssDNA is then coated with Replication Pro-
tein A (RPA) to protect it from nuclease attacks as well 
as mediate the subsequent recombination steps [18]. 
With assistance from mediator proteins like Rad52, 
Rad55-57 and others, Rad51 displaces RPA and binds 
the ssDNA to form the nucleoprotein filament [18, 21, 
22]. The Rad51 coated nucleoprotein filament then 
catalyzes strand invasion on a homologous region 
of another duplex to form an intermediate structure 
referred to as the displacement loop (D-loop), follow-
ing which the invading 3′ end primes DNA synthe-
sis [18]. The formation of the junction intermediate 
is the synapsis stage. During post-synapsis, junction 
intermediates are processed to form mature recom-
binant products [23]. How the intermediates are pro-
cessed largely depends on the nature of the break and 
the genomic environment [23]. There are six major 
pathways using HR, also referred to as HR sub-path-
ways [18]. The models for the general scheme of HR 
and its sub-pathways derive mainly from analyses of 
patterns of segregation of genetic markers in fungal 
crosses [24, 25]. These sub-pathways include (1) The 
canonical DSBR pathway, (2) synthesis-dependent 
strand annealing (SDSA), (3) break-induced replica-
tion (BIR), (4) single-strand annealing (SSA), (5) alter-
native (microhomology-mediated) end joining (alt-EJ/
MMEJ) and (6) RNA-templated DSBR.
Major DNA repair pathways using homologous 
recombination
Double strand break repair (DSBR) pathway
One of the most preeminent models of HR is the DSBR 
model published by Szostak et  al. [26]. This model 
proposes that once a DSB is formed, recombination is 
initiated at the site of the break [27]. This triggers the 
resection of DSB by a nuclease, degrading the 5′ ended 
strand to form a DNA molecule with a ssDNA tail ter-
minating with a 3′OH moiety [18]. The ssDNA coated 
with RPA is then replaced by the Rad51 recombinase 
in a reaction facilitated by mediator proteins Rad52, 
Rad55–57 and others [28]. The Rad51 protein coated 
on the ssDNA forming a nucleoprotein filament then 
locates and pairs with an intact homologous DNA mol-
ecule, followed by which the ssDNA tail invades the 
duplex to form a structure called the D-loop with the 
assistance of the DNA translocases Rad54 [29]. DNA 
synthesis is primed from 3′ end of the invading strand 
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resulting in the extension of the D-loop, which exposes 
DNA that is complementary to the ssDNA tail at the 
other end of the break. This tail anneals to the D-loop 
in a process that is referred to as second end capture 
(SCE) [29]. Further DNA synthesis and the sealing of 
strand nicks by DNA ligases allows linkage of the two 
DNA molecules by a two four-way DNA junction. These 
junctions are called Holliday junctions (HJ) [30]. To 
facilitate segregation of the two HJs, also referred to as 
the double Holliday Junction (dHJ), the four-way DNA 
structure undergoes endonucleatic cleavage of a pair of 
symmetrically related strand at each junction. This frac-
tures the connection between the two DNA molecules 
resulting in the formation of nicked linear duplexes and 
can be repaired by DNA ligases [30]. A notable hallmark 
of DSBR is that the choice of strand cleaved at each 
junction determines the type of recombinant DNA mol-
ecule generated (Fig.  1). If different pair of strands are 
cleaved at each junction, there is a reciprocal exchange 
of DNA arm flanking the site of recombination generat-
ing crossover recombinants (CO). However, if the same 
strands are cleaved at each junction the DNA arms do 
not exchange and this type of product is called a non-
crossover (NCO) [23, 31].
Synthesis‑dependent strand annealing (SDSA) pathway
Like the DSBR model, recombination by SDSA is initi-
ated at DSBs, and the 3′-end of the invading strand func-
tions as a primer for DNA synthesis (Fig.  1). However, 
instead of dHJ formation, in the SDSA pathway a short 
D-loop is formed, that is dissolved before the SCE occurs. 
The newly synthesized strand is then annealed to the 
complementary end of the second tail. As a consequence, 
no dHJ structure is formed leading to exclusively NCO 
recombinant products [32]. In yeast mitotic cells there 
are two helicases that promotes SDSA, and in doing so 
suppresses CO recombination [32]. Both these heli-
cases, Srs2 and Mph1 bind Rad51 and disrupt the Rad51 
presynaptic filaments thereby dissociating the D-loop 
[32–36].
Break‑induced replication (BIR) pathway
Break-induced replication is a preferred pathway of 
repairing DSBs that are one-sided and hence only one of 
the end shares homology with an intact DNA sequence 
(Fig. 1) [37]. Albeit mutagenic, BIR is useful for restart-
ing replication at broken forks. In the absence of SCE, 
extension of the invading strand accompanied by branch 
migration of the D-loop continues until the end of the 
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Fig. 1 HR and its sub-pathways. This figure is adapted from [59, 83, 84]. Multiple HR pathways through which DSB’s can be repaired give rise to 
either crossovers or non-crossover recombinants. SSA and MMEJ are typically mutagenic as they result in the loss of intervening DNA sequences at 
the break site. In SDSA, Rad51-mediated strand invasion is terminated before second end capture and prevents the formation of dHJ. In DSBR, after 
the Rad51 nucleofilament invades homologous DNA molecule, new DNA synthesis is primed from the 3′ end of the invading strand resulting in 
second end capture and subsequent dHJ formation. dHJ can either by resolved by the action of junction resolving enzymes or alternatively by the 
dissolution of the structure. The recombinant outcome of each subpathway, crossover or non- crossover, is indicated
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template chromosome or termination by meeting the 
converging fork [38].
Single‑strand annealing (SSA) pathway
Single-strand annealing is also a mutagenic HR sub-path-
way. The most common substrate for the SSA pathway is 
DSBs that are flanked by homologous sequences such as 
found in regions of repeated DNA sequences (Fig. 1). It 
is a unique HR sub-pathway in that it does not require 
the Rad51-dependent strand invasion step for homolo-
gous strand pairing. Instead, it is mediated by an addi-
tional Rad52 enzymatic activity that is unique for ssDNA 
annealing [29, 39, 40]. Resection of the DSB exposes com-
plementary 3′ ssDNA tails that anneal to each other. The 
non-homologous DNA between the annealed repeats is 
flipped out, forming 3′ flaps, which is then cleaved by the 
Rad1–Rad10 complex [40]. This results in the deletion 
of one of the repeats as well as the intervening region 
[40, 41]. Since, repetitive elements are numerous in the 
human genome; consequently SSA could mediate large-
scale rearrangements that cause deletions of sequences 
located between the repeats.
Alternative (microhomology‑mediated) end joining (alt‑EJ/
MMEJ)
Microhomology-mediated end joining is also a muta-
genic repair pathway. Although related to NHEJ, this 
pathway shares key mechanistic attributes with HR [42]. 
MMEJ, like HR, operates predominantly during S-phase 
of the cell cycle, in a Ku- and DNA-PK-independent fash-
ion. MMEJ begins with the resection of 5′ DNA ends at 
the DSB, leaving behind 3′ ssDNA [42]. Although MMEJ 
and DSBR employ the same end processing enzymes, 
subsequent steps diverge. MMEJ occurs when end-resec-
tion exposes micro-homologies of 10–25 bp that enables 
ssDNA to anneal [42]. This creates a substrate that, fol-
lowing removal of non-annealed DNA ends, is proficient 
for gap filling and ligation, like in SSA repair (Fig. 1) [43, 
44].
RNA‑templated DSBR
A crucial limitation of HR is that it requires an undam-
aged template, to restore the information on the dam-
aged duplex. If the DSB arises at a locus that has been 
replicated, a template is available in the form of a sister 
chromatid. Thus, while HR allows for accurate repair 
by a sister chromatid in mitotic cells, it is limited to the 
S and G2 phases of the cell cycle. If, however, the DSB 
occurs before replication, no such DNA template is avail-
able. The RNA transcript can at least in principle act as 
a repair template, this is referred to as RNA-templated 
DNA repair [45]. A role for RNA in DNA repair via NHEJ 
following reverse transcription into complementary 
DNA (cDNA) has been illustrated [46]. In this section, 
we will discuss the current findings in DSBR by RNA via 
HR mechanism.
RNA‑templated DSBR mediated by HR
Since RNA molecules are complementary copies of the 
DNA from which they are derived, several laboratories 
have tried to elucidate a direct role of RNA as a template 
in DNA repair (Fig.  2). More recently, studies in both 
yeast and human cells have shown evidence of direct 
RNA-templated DNA repair by HR. In the yeast Saccha-
romyces cerevisiae, Resnick et al. measured the repair of a 
linearized leu2 marker locus in yeast chromosomal DNA 
leading to Leu+ transformants through recombination 
with RNA oligonucleotides complementary to the broken 
ends that were transformed into the cells [45]. This com-
bined with the observations that in  vitro, the yeast rep-
licative DNA polymerases such as α and δ can replicate 
short RNA template tracts led them to conclude that RNA 
oligonucleotides can directly template the repair of a DSB 
in yeast cells [45]. Subsequently, Storici et al. showed that 
direct RNA-templated DNA repair by HR is not restricted 
to yeast but is an evolutionarily conserved phenomenon. 
They demonstrated the repair of a chromosomal break 
generated within a copy of the GFP gene cut by the I-SceI 
endonuclease and then repaired by RNA-containing and 
RNA-only oligonucleotides in the genome of human 
HEK-293 cells [47]. These findings demonstrate that the 
genetic information on transcript RNA can be used to 
repair DSBs (Fig.  2). RNA-dependent DSBR much like 
DNA-dependent DSBR works by the process of HR and 
involves the RAD52 epistasis group of genes, encoding 
proteins such as Rad51, Rad52 and XRCC3 [48].
HR mediated by cDNA intermediates
cDNA is a short dsDNA intermediate, which results 
from reverse transcription of endogenous cellular RNA. 
Since like the precursor RNA, cDNA may have sequence 
homology with regions around a DSB, it raises the pos-
sibility that a cDNA reverse transcript might mediate 
DSBR (Fig. 2). This was demonstrated by a system devel-
oped by Derr et al., the plasmid used in the study carries 
a his3 reporter gene whose coding sequence is inter-
rupted by an artificial intron inserted at a unique MscI 
site in the antisense orientation relative to the HIS3 pro-
moter [49]. The gene cassette is under the control of an 
inducible galactose promoter, which upon induction pro-
duces a sliceable his3 transcript [49]. This transcript can 
be subsequently reverse transcribed by Ty and integrated 
into the genome resulting in His+ prototrophic cells in 
a strain containing chromosomal his3 deletion [49]. Derr 
et  al. observed His+ prototrophic cells at a frequency 
of around 200 per 109, which could only result from 
Page 5 of 8Bhattacharjee and Nandi  Clin Trans Med  (2016) 5:45 
recombination between the HIS3 cDNA and chromo-
somal his3-∆Msc1 allele [49]. These findings demonstrate 
that like with the RNA transcript, genetic information on 
cDNA molecule can be used to repair DSBs (Fig. 2).
The regulation of Homologous Recombination
Although HR is an important DNA repair mechanism 
that protects genome integrity, it also has the ability to 
threaten the genome and cause cancer or cell death. As 
described above a key feature of HR is that it can use any 
homologous DNA sequences in the genome as substrate. 
Use of the homologous chromosome instead of the sis-
ter chromatid in diploid organisms can potentially lead 
to loss of heterozygosity [50]. Faulty recombination can 
result in translocation events as well as expansion and 
contraction of tandem arrays demonstrating the need for 
the tight regulation of recombination [27]. Interestingly, 
it is precisely the ability to promote genome rearrange-
ments that is used in some situations to beneficial effect, 
raising the question as to how cells have evolved the man-
datory controls to grant beneficial rearrangements but at 
the same time inhibiting those that would be harmful 
[51]. Since HR is limited to S and G2 phases, its regula-
tion is linked to the cell cycle apparatus. DSB formation 
during late S-phase or G2 phase initiates a DNA damage 
checkpoint that forestalls cells from progressing through 
mitosis until DNA is repaired [52]. Additionally, as stated 
earlier, whether DSBs are ‘clean’ or ‘dirty’ can influence 
both the pathway used to repair a DSB, and the kinetics 
of repair. The commitment to HR is established after the 
CDK1-dependent DSB resection [53, 54]. CDK1-depend-
ent phosphorylation of CtIP is crucial for its recruitment 
to the break site where it activates the Mre11 nuclease 
[55, 56]. In the absence of phosphorylated CtIP, NHEJ is 
the preferred pathway for DSBR because the unresected 
DSBs act as perfect substrates for binding of Ku proteins 
that initiate NHEJ [53].
Another key focus of the regulation of HR is the for-
mation of the presynaptic filament and the resolution of 
junction intermediates. Once the DNA ends are resected 
and ssDNA is formed, it is rapidly bound by RPA, which 
is important to protect the substrate from exonucleases 
and the formation of secondary DNA structures, but 
blocks its access from Rad51 [56]. Important positive 
mediators of nucleofilament formation include, Rad52, 
other Rad51 paralogs and BRCA2 in mammalian cells 
that have roles in promoting presynaptic filament for-
mation by helping overcome the inhibitory effect of RPA 
[21, 57]. The mediators act by stabilizing the ATPase 
activity of Rad51 and in turn enhancing its ability to bind 
ssDNA [58, 59]. Conversely, many factors negatively reg-
ulate RAD51 nucleofilament formation to ensure strand 
exchange regulation. For instance, once RAD51 is bound, 
it is actively debarked by helicase Fbh1 [56]. In S. cere-
visiae, Srs2 negatively regulates HR by removing Rad51 
from presynaptic filaments through an ATP-hydrolyz-
ing activity coupled to DNA unwinding and channeling 
lesions into the non-recombinogenic Rad6–Rad18 medi-
ated post replication repair pathway [33, 60, 61].
The checkpoint protein ATM regulates the synap-
tic step by controlling the activation of Rad54 [62, 63]. 
Rad54 activation is crucial for Rad51 mediated homology 
search, strand invasion, D-loop formation and junction 
resolution [62].
Another primary focus of HR regulation is the fate of 
HJ intermediates. In mitotic cells, COs are strongly sup-
pressed by tightly modulating the orientation of dHJ 
cleavage. Several DNA helicases have been implicated in 
regulating HR by “resolving” recombination intermedi-
ates as NCOs. RecQ helicases in both yeast and humans 
have been shown to negatively regulate CO recombinants 
by modulating various steps of HR like displacing RAD51 
from ssDNA in an ATP-dependent manner, displac-
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Fig. 2 Models explaining RNA-templated DSBR and cDNA-templated DSBR. This figure is adapted from [85]
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[64–66]. Members of the FANCM family of helicases 
have been reported to promote SDSA-mediated NCO 
product formation by disrupting RAD51 coated D-loops 
[32, 67–69].
Homologous recombination in cancer diagnosis 
and treatment
As discussed earlier, HR and its sub pathways play a 
key role in protecting the genome against instability. In 
doing so HR plays a crucial role in cancer cell formation 
and its therapeutic response. Due to its role in maintain-
ing genome integrity, HR is often considered the dernier 
resort in preventing tumorigenesis [70]. On the other 
hand, unregulated HR or erroneous repair or replicative 
bypass of lesions can also lead to chromosomal transloca-
tions and genomic rearrangements, which results in the 
dominant negative effect of HR [71]. Many mutations in 
HR genes have been associated with cancers, e.g., BRCA1 
and BRCA2 in breast and ovarian cancer [72]; RAD54 
in colon cancer [73]; MRN complex in melanoma, ovar-
ian, colorectal, and head and neck cancer [74]; RECQL4 
in skin carcinomas [75] and other well-characterized 
helicases. This evidence makes it abundantly clear that 
HR defects and defects in DNA damage response (DDR) 
cause cancer and are common in cancer cells. Taken 
together, this suggests that targeting HR is a valid anti-
cancer strategy.
Combination therapy: targeting synthetic lethal 
interactions
Promising data from both preclinical and clinical studies 
have given rise to the powerful concept for therapeutic 
combinations of DNA repair inhibitors with DNA dam-
aging anticancer agent [76]. This is known as condi-
tional (synthetic) lethality or combination therapy. This 
strategy is rooted in the principles from yeast genetics 
where mutants of either two related genes are viable, but 
loss of both genes functioning in a redundant pathway 
causes cell death [76]. This strategy allows for the tar-
geted killing of tumor cells by inhibiting genes, which are 
synthetic lethal, with a mutated tumor suppressor gene 
by developing cocktails of cytotoxic agents and inhibi-
tors of DNA repair [77]. The best-characterized can-
didates in this principle are the PARP inhibitors, which 
are selectively active in BRCA2-deficient tumors. Since 
BRCA2-deficient tumors cannot repair DSBs by HR, 
they rely on NHEJ. PARP is a central component in the 
base excision repair (BER) pathway and PARP inhibition 
abolishes the BER pathway, leading to a further accumu-
lation of unresolved SSBs that convert to DSBs during 
S phase. In these tumor cells, although NHEJ is active, 
it cannot compensate for the loss of both HR and BER. 
This leads to the accumulation of recombinogenic lesions 
and other errors that cause the collapse of replication 
forks and lead to cell death [78, 79]. Another example of 
rationale drug combination is the association of check-
point protein and DNA-dependent protein kinase (DNA-
PK) inhibitors. DNA-PK, belongs to the PI3-K related 
kinase family and is a component of the NHEJ pathway 
[80, 81]. DNA-PK inhibitors have been shown to have a 
synthetic lethal relationship with ATM-deficient tumors 
[80]. Several inhibitors identified using the combinato-
rial therapy approach are now in various stages of clini-
cal trials. For instance, Helleday laboratory has reported 
promising data using PARP inhibitors that can selectively 
kill BRCA1 and BRCA2 defective tumors [82]. FDA has 
recently accepted a drug named Rucaparib for priority 
review for the treatment of advanced mutant BRCA ovar-
ian cancer (S1). A PARP inhibitor drug Lynparza (Olapa-
rib) has also been recently approved by the FDA for the 
treatment of patients with germline BRCA-mutated 
advanced ovarian cancer (S2). Interestingly, myChoice 
HRD test developed by Myriad Genetics is a homologous 
recombination deficiency biomarker that indicates the 
inability of cancer cells to repair dsDNA breaks, result-
ing in increased susceptibility to PARP inhibitors and 
platinum-based therapies (S3). Overall, the link between 
cancer and HR provides the basis for the use of inhibitors 
against HR genes in therapy (Additional file 1).
Future perspectives
The implication of understanding the molecular details 
of HR in determining vital targets for cancer therapies is 
the perfect marriage of basic research and translational 
science. The HR pathway is an appealing target for the 
development of inhibitors because cancer cells rely on 
HR proteins for repair of DSBs, which arise as a conse-
quence of chemotherapy. The strategy of synthetic lethal-
ity has been validated by research and clinical trials. The 
recent success of PARP inhibitors in BRCA2-deficient 
breast and ovarian cancer has made the promise of inhib-
itors of DNA repair to transform the therapeutic land-
scape in cancer more apparent. Better characterization of 
DNA repair proteins will allow therapies that specifically 
target selected repair pathways for more effective repair 
inhibitors and to achieve cancer cure. Challenges in this 
field lie in the heterogeneity in the levels of HR proteins 
in different types of tumors, the lack of reliable biomark-
ers to validate resistance to the inhibitors, development 
of early molecular diagnostic tools and the evolution 
of resistance by cancer cells from acquiring additional 
mutations. Although more research is required to 
develop more targeted inhibitors of HR, there is no 
denying that further studies on the mechanistic roles of 
enzymes mediating DNA repair pathways have immense 
therapeutic potential.
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